SUBSCRIBE
SUBSCRIBE

Series B

Crowdfunding concept with money icon and human hands in retro 80s collage mixed media vector illustration. Idea for financing business project, funding, philanthropy, cooperation, bank credit and startup development.
Business
Fledgling Obesity Biotech Metsera Raises Another $215M for Long-Acting GLP-1
Despite crowding in the next-gen weight loss space, Metsera has raised over $500 million since its April launch, indicating a continued appetite for these drugs.
November 13, 2024
 · 
2 min read
 · 
Kate Goodwin
Art collage, hands and falling coins in orange circle. Modern design of finance and business.
Funding
Seaport, Six Months Out of Stealth, Comes Back for $225M Raise
Seaport Therapeutics, kick started by the former leaders of Karuna Therapeutics, has raised $225 million in an oversubscribed Series B to fund a pipeline of neuropsychiatric medicines.
October 21, 2024
 · 
1 min read
 · 
Annalee Armstrong
3D illustration of bacteria with their genetic material visible
Series B
George Church Startup Nets $60M to Take Non-Standard Amino Acids to the Clinic
GRO Biosciences will use the Series B funds to launch a Phase I trial for ProGly-Uricase, its investigational therapy for gout.
July 19, 2024
 · 
2 min read
 · 
Tristan Manalac
PRESS RELEASES
Press Releases
Metsera Secures $215 Million Series B Financing to Further Accelerate Portfolio
November 13, 2024
 · 
6 min read
Press Releases
TRexBio Announces $84 Million Series B Financing to Advance Pipeline of First-in-Class Immunology Programs into Clinical Development
November 13, 2024
 · 
4 min read
Press Releases
Inquis Medical Announces $40 Million Series B Financing to Accelerate Advancement of Aventus Thrombectomy System Addressing Venus Thromboembolic Diseases
November 4, 2024
 · 
3 min read
Press Releases
SynOx Therapeutics Adds New Investor and Capital to Series B Financing, Raising Total to $92 Million, and Doses First Patients in Phase 3 Trial
October 30, 2024
 · 
5 min read
Press Releases
INBRAIN Neuroelectronics Raises $50M Series B to Advance Graphene-Based Brain-Computer Interface Technology
October 29, 2024
 · 
4 min read
Press Releases
Aignostics Secures $34 Million Series B to Enhance Precision Medicine with AI
October 29, 2024
 · 
4 min read
Press Releases
AvenCell Raises $112 Million in Series B; Funding Led by Novo Holdings
October 22, 2024
 · 
4 min read
Press Releases
PureTech Founded Entity Seaport Therapeutics Closes $225 Million Oversubscribed Series B Financing Round
October 21, 2024
 · 
11 min read
Press Releases
Seaport Therapeutics Closes $225 Million Oversubscribed Series B Financing Round
October 21, 2024
 · 
5 min read
Press Releases
Terray Therapeutics Closes Oversubscribed $120M Series B to Advance Its Generative AI Pipeline of Small Molecule Therapeutics to the Clinic
October 18, 2024
 · 
3 min read
Press Releases
Ikerian Announces Series B Funding First close of USD 8M (CHF 6.73M) Led by Sanoptis with Commercial Agreement to Expand RetinAI Discovery in Europe
October 16, 2024
 · 
7 min read
Press Releases
Purespring Therapeutics raises £80/$105 million in a Series B financing to transform the treatment of kidney diseases
October 10, 2024
 · 
6 min read
Press Releases
ShiraTronics Raises $66 Million in Oversubscribed Series B Financing to Advance Pioneering Treatment for Chronic Migraine
October 9, 2024
 · 
5 min read
Press Releases
Amprion Announces Initial Close of a $15M Financing to Commercialize Groundbreaking Neurologic Diagnostics
October 9, 2024
 · 
3 min read
Press Releases
Purespring Therapeutics raises £80/$105 million in a Series B financing to transform the treatment of kidney diseases
October 9, 2024
 · 
6 min read
Press Releases
Basecamp Research Initiates Genetic Medicine Collaboration with the Liu Laboratory and Completes $60 Million Series B Financing
October 9, 2024
 · 
4 min read
Press Releases
Rege Nephro Co., Ltd. Successfully Completes Series B Funding to Accelerate Kidney Disease Therapy Trials
October 8, 2024
 · 
3 min read
Press Releases
Enara Bio raises $32.5 million Series B financing to advance first-in-class pipeline of TCR-based immunotherapies targeting novel Dark Antigens®
October 3, 2024
 · 
5 min read
Press Releases
Triveni Bio Raises $115 Million Series B Financing to Expand Pipeline of Therapeutics Addressing Immunological and Inflammatory (I&I) Disorders
October 2, 2024
 · 
2 min read
Press Releases
Aktis Oncology Announces $175 Million Oversubscribed Series B Financing to Further Advance Its Proprietary Radiopharmaceutical Pipeline
October 1, 2024
 · 
3 min read
Load More